Multiple Sclerosis info: Cannabis drug for Treating Patients
A “Sativex” drug derived from cannabis, which many people with multiple sclerosis say helps To ease their symptoms. This drug is a hope for million patients with MS. Sativex (R) is a cannabis-based drug containing delta 9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a 1:1 ratio, delivered in an oromucosal (mouth) spray.It has been approved as adjunctive treatment for neuropathic pain in patients with multiple sclerosis (MS).In new guidelines for the diagnosis and treatment of people with the disabling disease, the Multiple Sclerosis info National Institute for Health and Care Excellence (Nice) says the price set by the manufacturer of Sativex (nabiximols) is high for the benefit it gives patients.
According to Health Multiple Sclerosis info Canada, Sativex is thought to act via cannabinoid receptors that are distributed throughout the central nervous system and in immune cells. Sativex’s exact mechanism of action in relieving neuropathic pain is not known.“Sativex large Multiple Sclerosis info studies presented today show new supportive evidence in Multiple Sclerosis info clinical practice on the effectiveness and tolerability of Sativex as the first cannabinoid based treatment for resistant spasticity in all types of MS,” Maria Trojano, MD, Professor of Neurology and Head of the Department of Basic Medical Sciences Neuroscience and Sensory Organs at the University of Bariin Italy said in an Almirall release.